Teligent, Inc. (TLGT): Price and Financial Metrics
GET POWR RATINGS... FREE!
TLGT Stock Price Chart Interactive Chart >
TLGT Price/Volume Stats
| Current price | $0.17 | 52-week high | $1.60 |
| Prev. close | $0.20 | 52-week low | $0.17 |
| Day low | $0.17 | Volume | 73,687,200 |
| Day high | $0.21 | Avg. volume | 5,280,363 |
| 50-day MA | $0.38 | Dividend yield | N/A |
| 200-day MA | $0.63 | Market Cap | 16.10M |
Teligent, Inc. (TLGT) Company Bio
Teligent Inc. is a specialty generic pharmaceutical company developing, manufacturing, and marketing topical formulations in the United States. The company was founded in 1977 and is based in Buena, New Jersey.
Latest TLGT News From Around the Web
Below are the latest news stories about Teligent Inc that investors may wish to consider to help them evaluate TLGT as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayGood morning! |
22 Stocks Moving in Friday's Pre-Market SessionGainers LM Funding America, Inc. (NASDAQ: LMFA) rose 39.5% to $4.80 in pre-market trading after declining around 15% on Thursday. The company recently announced it purchased an additional 4,000 S19J Pro Antminer Machines for a price of $25.3 million to further expand the company's mining capabilities. ABVC BioPharma, Inc. (NASDAQ: ABVC) rose 24.4% to $3.06 in pre-market trading after gaining around 5% on Thursday. ABVC BioPharma recently restructured its joint venture with Lucida. Avadel Pharmac |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayGood morning, investor! |
Generic drug maker Teligent files for bankruptcy protection, explores sale of the companySouth Jersey specialty generic pharmaceutical firm Teligent Inc. filed for voluntarily bankruptcy protection on Thursday as it pursues the sale of the company or its core assets. Teligent Inc. of Buena in Atlantic County also said it is arranging for $12 million debtor-in-possession financing from its senior secured lenders. The company also announced that CEO Tim Sawyer and Philip Yachmetz, Teligent's chief legal officer and executive vice president, resigned effective Oct. 8. |
Teligent to Pursue Asset Sale through Voluntary Chapter 11 ProcessTeligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company ("Teligent" or the "Company"), today announced that the Company has, together with certain of its affiliates, filed for voluntary protection under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware to pursue a sale process that is intended to maximize the value of the Company. |
TLGT Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | -68.97% |
| 3-year | -97.30% |
| 5-year | -99.81% |
| YTD | N/A |
| 2021 | 0.00% |
| 2020 | -82.39% |
| 2019 | -68.91% |
| 2018 | -62.26% |
| 2017 | -45.08% |
Continue Researching TLGT
Want to see what other sources are saying about Teligent Inc's financials and stock price? Try the links below:Teligent Inc (TLGT) Stock Price | Nasdaq
Teligent Inc (TLGT) Stock Quote, History and News - Yahoo Finance
Teligent Inc (TLGT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...